| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 85656493 | FILING DATE | 06/20/2012 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | LEHKER, DAWN FELDMAN |
L.O. ASSIGNED | 111 |
PUB INFORMATION |
|||
| RUN DATE | 02/06/2014 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 02/05/2014 | ||
| LITERAL MARK ELEMENT | REVERSE TRANSLATIONAL MEDICINE | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | REVERSE TRANSLATIONAL MEDICINE |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Neurimmune Holding AG |
| ADDRESS | Wagistrasse 13 Schlieren, 8952 |
| ENTITY | 99-aktiengesellschaft |
| CITIZENSHIP | Switzerland |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; industrial chemicals; chemical preparations for scientific purposes, other than for medical or veterinary purposes; chemical preparations for use in photography; biological preparations for use in cell cultures other than for medical or veterinary purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biochemicals, namely, synthetic polypeptides made from amino acids that do not derive from animals for use in diagnostic and therapeutic agents |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biological preparations for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biocides; diagnostic preparations for medical and veterinary use; sanitary towels; Dietetic food, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes, namely, dietetic bread and dietetic noodles; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, namely, dietetic tea; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes, namely, low calorie or reduced calorie fruit beverages; Protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; Consultation and providing information about testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testing, inspection or research of medical treatment and technique; scientific research about health care; biology research; computer software design, computer programming, or maintenance of computer software; computer hardware design and development; computer software design and development |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | Color is not claimed as a feature of the mark. |
| DISCLAIMER W/PREDETER TXT | "TRANSLATIONAL MEDICINE" |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 02/05/2014 | ALIE | A | ASSIGNED TO LIE | 035 |
| 02/05/2014 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 034 |
| 02/05/2014 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 033 |
| 02/05/2014 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 032 |
| 02/05/2014 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 031 |
| 02/05/2014 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 030 |
| 11/04/2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 029 |
| 11/04/2013 | GNRT | O | NON-FINAL ACTION E-MAILED | 028 |
| 11/04/2013 | CNRT | R | NON-FINAL ACTION WRITTEN | 027 |
| 10/25/2013 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | 026 |
| 10/20/2013 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | 025 |
| 10/10/2013 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 024 |
| 10/07/2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 023 |
| 10/07/2013 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 022 |
| 10/07/2013 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 021 |
| 10/07/2013 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 020 |
| 10/07/2013 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 019 |
| 10/07/2013 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | 018 |
| 09/28/2013 | ALIE | A | ASSIGNED TO LIE | 017 |
| 09/17/2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 016 |
| 09/16/2013 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 015 |
| 09/16/2013 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 014 |
| 09/16/2013 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 013 |
| 03/22/2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 012 |
| 03/22/2013 | GNRT | O | NON-FINAL ACTION E-MAILED | 011 |
| 03/22/2013 | CNRT | R | NON-FINAL ACTION WRITTEN | 010 |
| 02/14/2013 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
| 02/13/2013 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
| 02/13/2013 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 10/16/2012 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 10/16/2012 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 10/16/2012 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 10/05/2012 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 06/28/2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 06/23/2012 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Janice Housey |
| CORRESPONDENCE ADDRESS | JANICE HOUSEY SYMBUS LAW GROUP LLC PO BOX 11085 MC LEAN, VA 22102-7985 |
| DOMESTIC REPRESENTATIVE | Janice Housey |